What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Publication Nov 6, 2024
Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Christopher Ma, Vipul Jairath, Virginia Salitano

Publication Nov 25, 2021
Systematic Review: Disease Activity Indices for Immune Checkpoint Inhibitor-Associated Enterocolitis

Brian Feagan, Christopher Ma, Niels Vande Casteele, Vipul Jairath

Publication Nov 3, 2021
Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Brian Feagan, Claire E Parker, Vipul Jairath

Publication Sep 27, 2021
Underrepresentation of Minorities and Underreporting of Race and Ethnicity in Crohn’s Disease Clinical Trials

Christopher Ma, Malcolm Hogan, Rocio Sedano, Vipul Jairath

Publication Sep 14, 2021
Meta-Analysis of Gene Expression Disease Signatures in Colonic Biopsy Tissue From Patients With Ulcerative Colitis

Brian G Feagan, Guangyong Zou, Niels Vande Casteele, Vipul Jairath

Publication Jul 6, 2021
Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS)

Arjan Bredenoord, Brian Feagan, Christopher Ma, Evan Dellon, Vipul Jairath

Publication May 10, 2021
An Expert Consensus to Standardise the Assessment of Histological Disease Activity in Crohn’s Disease Clinical Trials

Brian Feagan, Christopher Ma, Geert D’Haens, Vipul Jairath